SUJIT SANSGIRY to United States
This is a "connection" page, showing publications SUJIT SANSGIRY has written about United States.
Connection Strength
1.313
-
Racial and Ethnic Disparities in Access to Care Among Adults with Cardiovascular Disease. J Health Care Poor Underserved. 2025; 36(1):96-114.
Score: 0.082
-
Racial and Ethnic Disparities in Perceived Health Status Among Patients With Cardiovascular Disease. Prev Chronic Dis. 2024 Nov 14; 21:E89.
Score: 0.082
-
Understanding of pharmacy students' knowledge of cannabis use disorders in recreational vs non-recreational use states. Curr Pharm Teach Learn. 2024 Dec; 16(12):102191.
Score: 0.081
-
Understanding racial disparities in health care expenditures for cervical cancer. J Manag Care Spec Pharm. 2024 Aug; 30(8):873-881.
Score: 0.080
-
Integrated curriculum in the United States pharmacy programs. Curr Pharm Teach Learn. 2024 Jul; 16(7):102094.
Score: 0.078
-
Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval. Clin Transl Oncol. 2024 Aug; 26(8):1908-1920.
Score: 0.078
-
Demographics of and Costs to Users of Chiropractic Services in the United States with Neck or Back Pain not Meeting Guideline-Based Minimum Treatment Frequency Thresholds. Altern Ther Health Med. 2023 May; 29(4):102-109.
Score: 0.073
-
Effect of inadequate care on diabetes complications and healthcare resource utilization during management of type 2 diabetes in the United States. Postgrad Med. 2022 Jun; 134(5):494-506.
Score: 0.068
-
Factors Associated with Entering the Prescription Drug Coverage Gap Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease. Popul Health Manag. 2021 04; 24(2):241-248.
Score: 0.060
-
Effect of coverage gap on healthcare utilization among Medicare beneficiaries with chronic obstructive pulmonary disorder. Curr Med Res Opin. 2019 02; 35(2):321-328.
Score: 0.053
-
Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool. J Manag Care Spec Pharm. 2016 Nov; 22(11):1293-1301.
Score: 0.047
-
Physician Perception of Patient Medication Adherence in a Cohort of Medicare Advantage Plans in Texas. J Manag Care Spec Pharm. 2016 Mar; 22(3):305-12.
Score: 0.045
-
The Role of Socioeconomic Status and Health Care Access in Breast Cancer Screening Compliance Among Hispanics. J Public Health Manag Pract. 2015 Sep-Oct; 21(5):467-76.
Score: 0.043
-
Use of and attitude toward complementary and alternative medicine: understanding the role of generational influence. Altern Ther Health Med. 2013 May-Jun; 19(3):10-5.
Score: 0.037
-
Effectiveness of FDA's new over-the-counter acetaminophen warning label in improving consumer risk perception of liver damage. J Clin Pharm Ther. 2012 Dec; 37(6):681-5.
Score: 0.035
-
Impact of electronic health records on nurses' productivity. Comput Inform Nurs. 2012 May; 30(5):237-41.
Score: 0.034
-
Risks, benefits, and issues in creating a behind-the-counter category of medications. J Am Pharm Assoc (2003). 2011 Jan-Feb; 51(1):26-39.
Score: 0.031
-
Impact of changes in reimbursement policies and institutional practice algorithm for utilization of erythropoietic-stimulating agents on treatment patterns and costs in anemic lymphoma patients. Support Care Cancer. 2010 Feb; 19(2):251-9.
Score: 0.029
-
Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine. J Am Pharm Assoc (2003). 2008 Jan-Feb; 48(1):52-7.
Score: 0.025
-
Pseudoephedrine laws in the US--are we doing enough? Ann Pharmacother. 2006 Jun; 40(6):1213-5.
Score: 0.023
-
Use of the Internet for medication purchases and health information: can we make it safer? Mayo Clin Proc. 2005 May; 80(5):704; author reply 704-5.
Score: 0.021
-
Over-the-counter product line extensions: have we reached the limit yet? J Am Geriatr Soc. 2004 Jul; 52(7):1223-4.
Score: 0.020
-
Pharmacist involvement in CPOE. Am J Health Syst Pharm. 2004 Apr 01; 61(7):723-4; author reply 724.
Score: 0.020
-
Inconsistency in DTCA practices by manufacturers: is it time to standardize print summaries? Value Health. 2004 Mar-Apr; 7(2):216-7.
Score: 0.019
-
Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data. J Manag Care Spec Pharm. 2023 May; 29(5):480-489.
Score: 0.018
-
Attitudes of physicians toward formularies and services provided by pharmacists. Manag Care Interface. 2003 Feb; 16(2):34-8.
Score: 0.018
-
Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional survey. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):511-517.e8.
Score: 0.018
-
Consumer involvement: effects on information processing from over-the-counter medication labels. Health Mark Q. 2001; 19(1):61-78.
Score: 0.016
-
Accuracy of information on printed over-the-counter drug advertisements. Health Mark Q. 1999; 17(2):7-18.
Score: 0.014
-
Readability of over-the-counter medication labels. J Am Pharm Assoc (Wash). 1997 Sep-Oct; NS37(5):522-8.
Score: 0.012
-
An investigative model evaluating how consumers process pictorial information on nonprescription medication labels. Health Mark Q. 1997; 14(4):71-90.
Score: 0.012
-
Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach. Res Social Adm Pharm. 2017 May - Jun; 13(3):503-512.
Score: 0.011
-
Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance. J Clin Gastroenterol. 2016 Mar; 50(3):258-65.
Score: 0.011
-
How the elderly and young adults differ in the decision making process of nonprescription medication purchases. Health Mark Q. 1996; 14(1):3-21.
Score: 0.011
-
Federally qualified health center patients and generic drug discount programs. J Health Care Poor Underserved. 2012 May; 23(2):875-83.
Score: 0.009